ArticleThe Journal of infectious diseases2026

Genomic Surveillance and Antigenic Characterization of Respiratory Syncytial Virus (RSV) in Spain During the 2023-2024 Season of Nirsevimab Administration.

María Iglesias-Caballero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.